Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-58|1|660|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study 
|1-6-1-59|1|663|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma s/c leg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-60|1|744|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-61|1|908|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-62|1|862|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-63|1|818|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-64|1|604|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-65|1|800|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-66|1|688|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-67|1|821|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-68|1|817|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-69|1|1018|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| liver nodular,MPATH: 549 - carcinoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-70|1|627|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-71|1|657|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-72|1|818|Other deterministic changes|Bone among musculo-skeletal system diseases|Inflammatory bone lesion swollen foot|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-73|1|814|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-74|1|705|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-75|1|649|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-76|1|570|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma,Abdo Mass|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-77|1|691|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary Fibroadenoma Axil Mass,MPATH: 266 - fibroadenoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-78|1|622|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-79|1|912|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-80|1|594|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma Mass on Back|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-81|1|961|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-82|1|760|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-83|1|887|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-84|1|864|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-85|1|782|Neoplasia benign|Other local manifestations and miscellaneus|s/c Benign lipoma Mass R side|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-86|1|471|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,Testicular Mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-87|1|753|Neoplasia malignant|Other local manifestations and miscellaneus| Metastasis from unidentified primary,Necrosis|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-88|1|632|Other deterministic changes|Whole body|R.Morgan|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-89|1|964|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|s/c mammary adenocarcinoma, Mass R foreleg,MPATH: 268 - adenocarcinoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-90|1|671|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-91|1|341|Other deterministic changes|Whole body|EE|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-92|1|341|Other deterministic changes|Whole body|EE|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-507|1|841|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-508|1|714|Degenerative changes|Lower respiratory system,MA: 0000415 - lung|++,MPATH: 181 - fibrosis|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-509|1|811|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-510|1|888|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-511|1|999|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-512|1|776|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-513|1|699|Other deterministic changes|Lower respiratory system|Possibly Emphysemia|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-514|1|675|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-515|1|900|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-516|1|739|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-517|1|922|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-518|1|803|Degenerative changes|Lower respiratory system,MA: 0000415 - lung|+,MPATH: 181 - fibrosis|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-519|1|816|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-520|1|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic Leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-521|1|707|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-522|1|778|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-523|1|763|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-524|1|733|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-525|1|889|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-526|1|778|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Malignant fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-527|1|946|Neoplasia malignant|Bloodvessels among cardiovascular system|Gut mass angiosarcoma|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-528|1|798|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-529|1|789|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-530|1|805|Neoplasia benign|Other local manifestations and miscellaneus|S/C Lipoma  L side|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-531|1|839|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-532|1|826|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-533|1|895|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-534|1|680|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-535|1|693|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-536|1|666|Neoplasia malignant|Integumentary system|Basal cell carcinoma skin abdominal mass|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-537|1|763|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|+,MPATH: 1 - cell and tissue damage|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-538|1|746|Other deterministic changes|Musculo-skeletal system|Myositis ? (s/c tail)|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-539|1|760|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-540|1|741|Other deterministic changes|Whole body|n/a|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-541|1|354|Other deterministic changes|Whole body|DEP|
1-6-1|n/a,n/a|1| 94|shamexposed|0|working level months|Injection intrapleural| sham exposed|71 (71 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats for short term study|1-6-1-542|1|354|Other deterministic changes|Whole body|DEP|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-93|2|929|Other deterministic changes|Whole body|EE|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-94|2|710|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-95|2|821|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-96|2|1027|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-97|2|744|Neoplasia benign|Other local manifestations and miscellaneus|Fibromyxoma sc mass|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-98|2|625|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Fat, Mammary Fibroadenoma, Abdominal Mass, R/Ribcage Mass,MPATH: 266 - fibroadenoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-99|2|663|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-100|2|768|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-101|2|824|Other deterministic changes|Other local manifestations and miscellaneus|Kidney mass, spleen enlarged, liver pale Complex pathology|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-102|2|768|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-103|2|737|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-104|2|711|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-105|2|862|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-106|2|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Spleen Lymphoblastic Leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-107|2|982|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-108|2|705|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-109|2|929|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-110|2|887|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-389|2|482|Neoplasia benign|Other local manifestations and miscellaneus|Mass on neck|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-617|2|712|Hyperplastic changes|Haematolymphatic system|Splenic hypertrophy|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-620|2|403|Other deterministic changes|Whole body|EE|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-621|2|403|Other deterministic changes|Whole body|EE|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-624|2|584|Other deterministic changes|Whole body|frozen no histology|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-656|2|795|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma Lside,MPATH: 408 - soft tissue fibrosarcoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-657|2|683|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-658|2|770|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-659|2|720|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-660|2|881|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-661|2|805|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-662|2|819|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|Macrophage aggregations+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-663|2|648|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-664|2|914|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|Bronchopneumonia,MPATH: 212 - inflammation|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-665|2|700|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-666|2|875|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-667|2|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Leukaemia,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-668|2|845|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-669|2|717|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|++,MPATH: 213 - acute inflammation|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-670|2|671|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-671|2|578|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-672|2|650|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-673|2|357|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma Jaw,MPATH: 408 - soft tissue fibrosarcoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-674|2|931|Neoplasia benign|Other local manifestations and miscellaneus|Fibromyxoma benign  L side|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-675|2|867|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-676|2|757|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-677|2|575|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma L/side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-678|2|561|Neoplasia malignant|Bone among musculo-skeletal system diseases|Chondrosarcoma abnormal tail|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-679|2|517|Other deterministic changes|Whole body|back mass specimen inadequate|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-680|2|752|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-681|2|575|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-682|2|972|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-683|2|826|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Granulomatous change R Testis|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-684|2|722|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-685|2|541|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-686|2|834|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-687|2|504|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Abdominal Mass Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-688|2|771|Hyperplastic changes|Lower respiratory system|+|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-689|2|556|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-690|2|715|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|*,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-691|2|847|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-692|2|665|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma R/Side Mass|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-693|2|587|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-694|2|840|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-695|2|816|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma, Focus of infection lobe A,MPATH: 408 - soft tissue fibrosarcoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-696|2|826|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-697|2|834|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-698|2|800|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-699|2|765|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-700|2|720|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-701|2|636|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|chronic nephritis,MPATH: 212 - inflammation|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-702|2|836|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-703|2|503|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-704|2|768|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-705|2|612|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-706|2|796|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-707|2|688|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-768|2|507|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Inflamed skin Swollen foot|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-769|2|770|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-770|2|879|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-771|2|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-772|2|312|Other deterministic changes|Whole body|SCREEN|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-773|2|312|Other deterministic changes|Whole body|SCREEN|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-774|2|312|Other deterministic changes|Whole body|SCREEN|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-775|2|312|Other deterministic changes|Whole body|SCREEN|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-776|2|131|Other deterministic changes|Whole body|EE|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-777|2|131|Other deterministic changes|Whole body|EE|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-828|2|836|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|cystic kidneys,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-829|2|738|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-830|2|866|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-831|2|565|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-832|2|770|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-833|2|524|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-834|2|599|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-835|2|866|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-836|2|866|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-837|2|780|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-838|2|777|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-839|2|597|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-840|2|866|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-841|2|760|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|Malignant trichoepithelioma dorsal mass,MPATH: 218 - neoplasm|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-896|2|838|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-897|2|833|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-898|2|838|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-899|2|838|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-900|2|838|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-901|2|752|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-902|2|760|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-903|2|719|Degenerative changes|Lower respiratory system,MA: 0000415 - lung|+,MPATH: 181 - fibrosis|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-904|2|838|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-905|2|838|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-956|2|846|Neoplasia malignant|Lower respiratory system|Tumour 5<> 10mmTumour lobe C 4mm Lobe B a spongey mass ? Are there 2 tumors|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-957|2|830|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-958|2|833|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-959|2|780|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-960|2|846|Other deterministic changes|Whole body|n/a|
1-6-2|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|115 (115 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats for short term study|1-6-2-961|2|846|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-1|3|742|Hyperplastic changes|Lower respiratory system|+|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-2|3|726|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|+,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-3|3|744|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-4|3|706|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Benign Keratoacanthoma cystic mass R hindleg,MPATH: 218 - neoplasm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-5|3|811|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-6|3|699|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-7|3|743|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour <2mm Lobe A - 1cm, Lobe E - 4mm,MPATH: 268 - adenocarcinoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-8|3|705|Neoplasia benign|Other local manifestations and miscellaneus|Myxoma Rib Mass, Lobe C - 2mm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-9|3|860|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm, Mass lobe E|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-10|3|752|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-11|3|881|Hyperplastic changes|Lower respiratory system|+ Nodules on lung|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-12|3|776|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-13|3|776|Neoplasia benign|Other local manifestations and miscellaneus|fibroma abdo|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-14|3|809|Hyperplastic changes|Lower respiratory system|+|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-15|3|907|Hyperplastic changes|Lower respiratory system|+|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-16|3|712|Neoplasia benign|Lower respiratory system|Tumour 2<> 5mm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-17|3|906|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+ Lesions lobes A and C,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-18|3|479|Hyperplastic changes|Lower respiratory system|+ Adenomatosis|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-19|3|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Neck subcut. Abscess|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-20|3|713|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Keratoacanthoma cystic mass,MPATH: 218 - neoplasm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-21|3|618|Other deterministic changes|Whole body|leg mass|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-22|3|775|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 160 - metaplasia|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-23|3|673|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-24|3|850|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Bronchoalveolar adenocarcinomaMass lobe D onto lobe E,MPATH: 549 - carcinoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-25|3|957|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-26|3|684|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|mild nephritis,MPATH: 212 - inflammation|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-27|3|818|Hyperplastic changes|Lower respiratory system|+|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-28|3|791|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-29|3|744|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-30|3|776|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-31|3|829|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-32|3|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic Leukaemia Spleen, Liver, Lung,MPATH: 513 - Lymphoid neoplasms|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-33|3|975|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm,MPATH: 446 - squamous cell carcinoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-34|3|213|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-35|3|713|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-36|3|659|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-37|3|901|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic Kidney, salivary glands enlarged, Diaphragm lesions  Al Br with cholesterol clefts,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-38|3|409|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-39|3|881|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-40|3|900|Neoplasia malignant|Lower respiratory system|Tumour > 10mm 2cm mass lobe C|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-41|3|772|Neoplasia malignant|Lower respiratory system|Tumour 5<> 10mm Lobe A - 1cm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-42|3|704|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-43|3|699|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-44|3|685|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-45|3|829|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-46|3|768|Neoplasia malignant|Lower respiratory system|Tumour 5<> 10mm Lobe B - 1cm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-47|3|672|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-48|3|534|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-49|3|713|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-50|3|639|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-51|3|475|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-52|3|205|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma benign|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-53|3|101|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-54|3|101|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-55|3|128|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-56|3|128|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-57|3|957|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|kidneys cystic, Sebaceous hyperplasia,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-111|3|831|Hyperplastic changes|Lower respiratory system|+|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-112|3|720|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-113|3|780|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-114|3|835|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-115|3|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic Leukaemia Spleen, Kidney, 1cm B&E,MPATH: 513 - Lymphoid neoplasms|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-116|3|678|Hyperplastic changes|Lower respiratory system|+ Neck Mass, Lobe E - 2mm Sebaceous tissue|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-117|3|542|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-118|3|508|Hyperplastic changes|Lower respiratory system|+ Adenoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-119|3|880|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-120|3|596|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-121|3|667|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-122|3|500|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-123|3|790|Neoplasia benign|Other local manifestations and miscellaneus|s/c FibromyxomaPeritoneal mass|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-124|3|716|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-125|3|843|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-126|3|684|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,R/Ribs Mass, B-2mm,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-127|3|786|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-128|3|751|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-129|3|771|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-130|3|728|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-131|3|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Kidneys cystic, spleen enlarged lymphoblastic leukemia,MPATH: 513 - Lymphoid neoplasms|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-132|3|781|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|Extensive perivascular cuffing|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-133|3|853|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|+,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-134|3|760|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-135|3|790|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-136|3|590|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-137|3|831|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-138|3|542|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant rhabdomyosarcoma L foreleg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-139|3|918|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-140|3|670|Neoplasia benign|Lower respiratory system|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-141|3|842|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-142|3|806|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-143|3|792|Other deterministic changes|Lower respiratory system|+Macrophage aggregations in parenchyma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-144|3|775|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma sc,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-145|3|901|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma neck|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-146|3|587|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma intestinal mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-147|3|811|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma mass L neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-148|3|678|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma Leg Mass, LobeC - 1mm,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-149|3|915|Other deterministic changes|Integumentary system|+Keratin mass (benign) Abdo|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-150|3|563|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-151|3|801|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-152|3|615|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-153|3|766|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-154|3|555|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-155|3|790|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-156|3|678|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-157|3|801|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-158|3|591|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-159|3|838|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mmlung tumour lobe B 4mm,MPATH: 268 - adenocarcinoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-160|3|534|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-161|3|555|Other deterministic changes|Whole body|Type II hyperplasia|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-162|3|880|Neoplasia benign|Other local manifestations and miscellaneus|fibroma dorsal|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-163|3|129|Other deterministic changes|Whole body|EE|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-164|3|129|Other deterministic changes|Whole body|EE|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-165|3|114|Other deterministic changes|Whole body|DEP|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-166|3|114|Other deterministic changes|Whole body|DEP|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-167|3|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-168|3|754|Other deterministic changes|Integumentary system|Benign S/C Mass|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-169|3|783|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-170|3|768|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-171|3|873|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-172|3|782|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-173|3|803|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+ Patches on lobes,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-174|3|408|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-175|3|657|Other deterministic changes|Whole body|Fat + Normal mammary tissue|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-176|3|581|Other deterministic changes|Whole body|no histology provided|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-177|3|867|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-178|3|867|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-179|3|1013|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-180|3|807|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-181|3|602|Other deterministic changes|Lower digestive tract|Oesophageal Ulcer|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-182|3|346|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Branchial Cyst?  Salivary gland,MPATH: 62 - cyst|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-183|3|708|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|nflammation of Glandular tissue|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-184|3|773|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-185|3|613|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|chronic nephritis,MPATH: 212 - inflammation|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-186|3|590|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-187|3|669|Neoplasia benign|Lower respiratory system|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-188|3|823|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|Sq.cell carcinoma skin leg,MPATH: 446 - squamous cell carcinoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-189|3|836|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|kidney,MPATH: 62 - cyst|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-190|3|645|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-191|3|811|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-192|3|730|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-193|3|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-194|3|746|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Cystic KidneY,MPATH: 1 - cell and tissue damage|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-195|3|739|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-196|3|549|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-197|3|733|Degenerative changes|Lower respiratory system,MA: 0000415 - lung|+,MPATH: 181 - fibrosis|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-198|3|677|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary Fibroadenoma ,,Abdo Mass,MPATH: 266 - fibroadenoma|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-199|3|692|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Keratoacanthoma? Chest,MPATH: 218 - neoplasm|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-200|3|448|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-201|3|785|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-202|3|768|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-203|3|846|Neoplasia benign|Other local manifestations and miscellaneus|fibroma L side|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-204|3|590|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+ Lobe A - 1mm,MPATH: 213 - acute inflammation|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-205|3|699|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-206|3|592|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-207|3|806|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-208|3|762|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-209|3|686|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-210|3|635|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-211|3|600|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-212|3|536|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-213|3|606|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-214|3|485|Other deterministic changes|Lower respiratory system|lung abscess|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-215|3|892|Hyperplastic changes|Lower respiratory system|+|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-216|3|731|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-217|3|789|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-218|3|703|Other deterministic changes|Whole body|n/a|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-219|3|129|Other deterministic changes|Whole body|ee|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-220|3|129|Other deterministic changes|Whole body|ee|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-221|3|114|Other deterministic changes|Whole body|DEP|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-222|3|114|Other deterministic changes|Whole body|DEP|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-708|3|100|Other deterministic changes|Whole body|DEP|
1-6-3|n/a,n/a|1| 94|Rn-222 gas|200|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 174,195,250 254 WLM|171 (171 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study includingl 8 rats deposition and 6 rats for short term study|1-6-3-709|3|100|Other deterministic changes|Whole body|DEP|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-223|4|810|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-224|4|558|Neoplasia benign|Other local manifestations and miscellaneus|Fibromyxoma Lobe E-1mm,Dorsal Mass|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-225|4|735|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-226|4|542|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma Abdo,MPATH: 408 - soft tissue fibrosarcoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-227|4|799|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-228|4|798|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-229|4|633|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic Leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-230|4|354|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary adenoma benign ,Abdo Mass,MPATH: 218 - neoplasm|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-231|4|958|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-232|4|572|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-233|4|773|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-234|4|745|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-235|4|866|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-236|4|693|Hyperplastic changes|Lower respiratory system|+|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-237|4|716|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-238|4|707|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-239|4|917|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-240|4|776|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-241|4|785|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-242|4|523|Neoplasia benign|Other local manifestations and miscellaneus|fibroma leg  mass|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-243|4|700|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-244|4|382|Other deterministic changes|Whole body|no histology provided|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-245|4|766|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-246|4|871|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-247|4|785|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-248|4|572|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-249|4|1022|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-250|4|838|Neoplasia benign|Lower respiratory system|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-251|4|883|Neoplasia malignant|Bloodvessels among cardiovascular system|HeamangiosarcomaSI swollen|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-252|4|673|Hyperplastic changes|Lower respiratory system|+|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-253|4|775|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-254|4|796|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-255|4|679|Neoplasia benign|Other local manifestations and miscellaneus|fibroma Axill|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-256|4|617|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-257|4|967|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-258|4|617|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma L side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-259|4|889|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-260|4|828|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-261|4|838|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-262|4|537|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-263|4|846|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-264|4|774|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-265|4|949|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-266|4|613|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+pm change,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-267|4|673|Hyperplastic changes|Lower respiratory system|+|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-268|4|840|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-269|4|949|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|kidney cystuc,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-270|4|812|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-271|4|831|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-272|4|765|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-273|4|768|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-274|4|693|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-275|4|138|Other deterministic changes|Whole body|ee|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-276|4|138|Other deterministic changes|Whole body|ee|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-277|4|124|Other deterministic changes|Whole body|DEP|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-278|4|124|Other deterministic changes|Whole body|DEP|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-279|4|791|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-280|4|686|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-281|4|778|Hyperplastic changes|Haematolymphatic system|Reactive hyperplasia|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-282|4|621|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-283|4|823|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-284|4|768|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-285|4|802|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-286|4|788|Neoplasia benign|Lower respiratory system|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-287|4|621|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant rhabdomyosarcoma leg mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-288|4|879|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-289|4|739|Neoplasia malignant|Lower respiratory system|Tumour 5<> 10mm Mass, A - 1cm, E - 5mm|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-290|4|756|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-291|4|789|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-292|4|680|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-293|4|865|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-294|4|860|Hyperplastic changes|Lower respiratory system,MA: 0001480 - respiratory tract epithelium|+,MPATH: 134 - hyperplasia|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-295|4|773|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-296|4|740|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-297|4|778|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-298|4|563|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-299|4|730|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-300|4|786|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-301|4|917|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|++,MPATH: 213 - acute inflammation|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-302|4|783|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-303|4|938|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-304|4|727|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-305|4|778|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|abscess on back|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-306|4|640|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-307|4|833|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|+,MPATH: 212 - inflammation|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-308|4|653|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Mesentry granulomatous change|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-309|4|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia spleen,MPATH: 513 - Lymphoid neoplasms|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-310|4|792|Other deterministic changes|Hepato-pancreatic system|Liver rough Centrilobular necrosis|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-311|4|792|Neoplasia malignant|Other local manifestations and miscellaneus|+Leg swollen|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-312|4|680|Neoplasia benign|Integumentary system,MA: 0000151 - skin|+? Keratocanthoma Small mass R side, Lobe E - 3mm,MPATH: 218 - neoplasm|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-313|4|287|Other deterministic changes|Whole body|ee|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-314|4|287|Other deterministic changes|Whole body|ee|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-315|4|272|Other deterministic changes|Whole body|DEP|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-316|4|272|Other deterministic changes|Whole body|DEP|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-628|4|870|Other deterministic changes|Whole body|Thymus adherent to spine cyst in lymphoid tissue|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-629|4|755|Hyperplastic changes|Lower respiratory system|+Fat on dormant mammary tissue|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-630|4|691|Hyperplastic changes|Lower respiratory system|+|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-631|4|628|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|S/C Fibrosarcoma Abdo Mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-632|4|733|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma Lthorax,MPATH: 408 - soft tissue fibrosarcoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-633|4|706|Neoplasia benign|Other local manifestations and miscellaneus|fibroma  R neck|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-634|4|731|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma benign Lhind leg|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-635|4|706|Other deterministic changes|Whole body|Swollen leg|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-636|4|912|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-637|4|684|Other deterministic changes|Whole body|Perivascular/peribronchiolar mononuclear cuffing|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-638|4|779|Hyperplastic changes|Lower respiratory system|+White nodules on lung|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-639|4|686|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-640|4|688|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-641|4|706|Hyperplastic changes|Haematolymphatic system|Mass L chest not studied|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-642|4|810|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-643|4|852|Other deterministic changes|Whole body|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-644|4|789|Other deterministic changes|Musculo-skeletal system|Fibrous tissue poor specimen abdomen|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-645|4|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia t,MPATH: 513 - Lymphoid neoplasms|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-646|4|779|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-647|4|704|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-648|4|781|Neoplasia benign|Lower respiratory system|n/a|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-649|4|759|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-650|4|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic Leukaemia spleen,MPATH: 513 - Lymphoid neoplasms|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-651|4|793|Other deterministic changes|Mammary gland|Secreting mammary tissue,|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-652|4|684|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| Malignant skin tumour jaw metastesising to lobe C,MPATH: 446 - squamous cell carcinoma|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-653|4|856|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-654|4|783|Hyperplastic changes|Lower respiratory system|+|
1-6-4|n/a,n/a|1| 94|Rn-222 gas|400|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 382, 383, 390 WLM|122 (122 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 4 rats for short term study|1-6-4-655|4|720|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-317|5|826|Other deterministic changes|Reproductive system|Urinary bladder mass Pus filled glandular tissue|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-318|5|620|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-319|5|896|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm lung tumour lobe E 5mm|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-320|5|756|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-321|5|756|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-322|5|695|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-323|5|702|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-324|5|582|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-325|5|727|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-326|5|693|Hyperplastic changes|Lower respiratory system|+|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-327|5|792|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-328|5|274|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-329|5|762|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-330|5|645|Neoplasia benign|Other local manifestations and miscellaneus|fibroma leg|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-331|5|682|Other deterministic changes|Hepato-pancreatic system|Liver mostly blood non malignant, NAF|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-332|5|593|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-333|5|1001|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-334|5|700|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+ Lobe C - 0.5mm,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-335|5|771|Hyperplastic changes|Lower respiratory system|+|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-336|5|699|Hyperplastic changes|Lower respiratory system|+|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-337|5|734|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-338|5|630|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-339|5|815|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-340|5|679|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-341|5|771|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-342|5|679|Neoplasia benign|Other local manifestations and miscellaneus|fibroma R foreleg|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-343|5|855|Neoplasia malignant|Liver among hepato-pancreatic system diseases|Hepatocarcinoma,|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-344|5|743|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-345|5|847|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-346|5|910|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm lung tumour lobe B 3mm,MPATH: 446 - squamous cell carcinoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-347|5|788|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Kidneys cystic,MPATH: 62 - cyst|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-348|5|400|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus| Abdominal Cyst abscess|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-349|5|739|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-350|5|949|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-351|5|294|Other deterministic changes|Whole body|DEP|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-352|5|294|Other deterministic changes|Whole body|DEP|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-353|5|278|Other deterministic changes|Whole body|EE|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-354|5|278|Other deterministic changes|Whole body|EE|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-355|5|833|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-356|5|726|Other deterministic changes|Lower digestive tract|Inflammation of oesophagus/lungs|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-357|5|862|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-358|5|852|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm,MPATH: 549 - carcinoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-359|5|607|Neoplasia systemic|Haematolymphatic system|Myeloid Leukaemia spleen|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-360|5|558|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-361|5|756|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-362|5|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Malignant lymphoma liver,MPATH: 513 - Lymphoid neoplasms|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-363|5|832|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-364|5|627|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-365|5|860|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-366|5|778|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-367|5|860|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-368|5|644|Other deterministic changes|Lower respiratory system|Squamous metaplasia cyst|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-369|5|774|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-370|5|700|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma benign R foreleg|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-371|5|931|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|Early nephritis spleen predominant red pulp,MPATH: 212 - inflammation|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-372|5|308|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|puss filled abscess in muscle|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-373|5|837|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-374|5|760|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 160 - metaplasia|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-375|5|897|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-376|5|806|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-377|5|708|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-378|5|651|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ Pleural scarring,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-379|5|631|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary Fibroadenoma ,Mass Li side,MPATH: 266 - fibroadenoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-380|5|897|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-381|5|852|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-382|5|907|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-383|5|568|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-384|5|482|Other deterministic changes|Whole body|Lungs to Morgan|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-385|5|841|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-386|5|511|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-387|5|774|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-388|5|720|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-390|5|272|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-391|5|726|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+Lobe E - 3mm,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-392|5|574|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant rhabdomyosarcoma mass on R side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-393|5|812|Neoplasia benign|Other local manifestations and miscellaneus|sc lipoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-394|5|636|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-395|5|858|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney and liver rough surface liver NAF,MPATH: 1 - cell and tissue damage|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-396|5|674|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-397|5|753|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|S/C Fibrosarcoma neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-398|5|698|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-399|5|882|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-400|5|757|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-401|5|681|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-402|5|511|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma abdo,MPATH: 408 - soft tissue fibrosarcoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-403|5|784|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|advanced nephritis,MPATH: 212 - inflammation|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-404|5|545|Other deterministic changes|Whole body|Lungs to Morgan|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-405|5|907|Neoplasia malignant|Bloodvessels among cardiovascular system|GIT mass,heamangiosarcoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-406|5|866|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-407|5|840|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Kidneys cystic,MPATH: 62 - cyst|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-408|5|645|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-409|5|614|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-410|5|897|Neoplasia benign|Lower respiratory system|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-411|5|889|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-412|5|802|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-413|5|723|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-414|5|615|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-415|5|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-416|5|723|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-417|5|841|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-418|5|806|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-419|5|901|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma L side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-420|5|798|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-421|5|684|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-422|5|668|Other deterministic changes|Whole body|n/a|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-423|5|749|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-424|5|651|Hyperplastic changes|Lower respiratory system|+|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-425|5|316|Other deterministic changes|Whole body|EE|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-426|5|316|Other deterministic changes|Whole body|EE|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-625|5|293|Other deterministic changes|Whole body|DEP|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-710|5|309|Other deterministic changes|Whole body|EE|
1-6-5|n/a,n/a|1| 94|Rn-222 gas|800|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 785, 795 801 WLM|112 (112 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 4 rats deposition and 6 rats for short term study|1-6-5-711|5|309|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-427|6|692|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-428|6|600|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-429|6|711|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-430|6|744|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Squamous cartilaginous areas,MPATH: 268 - adenocarcinoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-431|6|338|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-432|6|338|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-433|6|825|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-434|6|674|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-435|6|835|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Mass, kidneys,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-436|6|786|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-437|6|766|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic C - small necrotic lesion with cholesterol clefts,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-438|6|642|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Swollen leg, Polycystic Kidney Dermatitis,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-439|6|908|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-440|6|487|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-441|6|630|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-442|6|638|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-443|6|844|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-444|6|866|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Possible granuloma Mass left side|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-445|6|741|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Possible granuloma left side|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-446|6|741|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+Polymorph infiltration of Mac Al,MPATH: 213 - acute inflammation|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-447|6|831|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma L foreleg|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-448|6|786|Neoplasia malignant|Lower respiratory system|Tumour > 10mmWhite masses in lobes, 2 cm mass lobe B|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-449|6|908|Neoplasia benign|Lower respiratory system|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-450|6|838|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-451|6|845|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+Liver white lesions,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-452|6|419|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Granulocyte infiltrated tissue,MPATH: 62 - cyst|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-453|6|845|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm lung tumours in lobes B 4mm and lobe E 3mm|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-454|6|1035|Neoplasia malignant|Other local manifestations and miscellaneus|malignant mesenchymoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-455|6|668|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-456|6|629|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-457|6|741|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-458|6|649|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-459|6|722|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-460|6|370|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary Fibroadenoma ,Abdo Mass,MPATH: 266 - fibroadenoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-461|6|318|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-462|6|318|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-463|6|293|Other deterministic changes|Whole body|Dep|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-464|6|293|Other deterministic changes|Whole body|Dep|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-465|6|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-466|6|773|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|Adenocarcinoma swollen adrenal,MPATH: 549 - carcinoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-467|6|855|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-468|6|648|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-469|6|744|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-470|6|716|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-471|6|741|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-472|6|573|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|abdominal mass,MPATH: 62 - cyst|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-473|6|738|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-474|6|573|Other deterministic changes|Whole body|R.Morgan no hist.|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-475|6|836|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-476|6|697|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-477|6|815|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma rib cage,MPATH: 408 - soft tissue fibrosarcoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-478|6|810|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000565 - mesothelium|Benign mesothelial tissue tumour,MPATH: 365 - mesothelioma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-479|6|787|Hyperplastic changes|Lower respiratory system|+|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-480|6|737|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-481|6|831|Other deterministic changes|Musculo-skeletal system|Mass L foreleg normal muscle|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-482|6|901|Neoplasia benign|Integumentary system,MA: 0000151 - skin|s/c Keratoacanthoma,MPATH: 218 - neoplasm|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-483|6|310|Other deterministic changes|Whole body|dep|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-484|6|310|Other deterministic changes|Whole body|dep|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-485|6|759|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm,MPATH: 446 - squamous cell carcinoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-486|6|500|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-487|6|833|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-488|6|789|Neoplasia malignant|Lower respiratory system|Tumour <2mm lung tumour lobe E 2mm|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-489|6|713|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-490|6|587|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-491|6|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia thymic stomach mass,MPATH: 513 - Lymphoid neoplasms|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-492|6|759|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-493|6|738|Neoplasia benign|Lower respiratory system|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-494|6|669|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|S/C Fibrosarcoma Abdomen,MPATH: 408 - soft tissue fibrosarcoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-495|6|662|Hyperplastic changes|Lower respiratory system|+Lobe D - 1mm|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-496|6|628|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 5<> 10mm D - 1cm, E - 0.5mm,MPATH: 268 - adenocarcinoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-497|6|732|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+Lungs pale speckled,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-498|6|601|Neoplasia benign|Other local manifestations and miscellaneus|fibroma  leg|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-499|6|923|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|Mixed malignant sarcoma/adenocarcinoma, throat,MPATH: 218 - neoplasm|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-500|6|802|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-501|6|704|Hyperplastic changes|Lower respiratory system|+|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-502|6|712|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-503|6|296|Other deterministic changes|Whole body|DEP|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-504|6|296|Other deterministic changes|Whole body|DEP|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-581|6|899|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-582|6|765|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-583|6|649|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|S/C Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-584|6|319|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|, Calcification of pulmonary artery|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-585|6|914|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Kidneys cystic Indication of cardiac failure,MPATH: 62 - cyst|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-586|6|898|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-587|6|837|Hyperplastic changes|Lower respiratory system|+|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-588|6|822|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-589|6|803|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-590|6|621|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-591|6|899|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kydney cystic, thymus enlarged (ln?),MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-592|6|695|Other deterministic changes|Whole body|Periph white cell count high|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-593|6|804|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-594|6|530|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant rhabdomyosarcoma Back mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-595|6|697|n/a|n/a|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-596|6|635|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+Lobe C - 3mm,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-597|6|775|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-598|6|733|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-599|6|803|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma L foreleg|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-600|6|712|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Lung tumour lobe E 1cm,MPATH: 446 - squamous cell carcinoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-601|6|572|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary Fibroadenoma ,Abdo Mass,MPATH: 266 - fibroadenoma|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-602|6|764|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-603|6|857|Neoplasia benign|Lower respiratory system|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-604|6|601|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Benign Keratoacanthoma abdomen,MPATH: 218 - neoplasm|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-605|6|950|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-606|6|380|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-607|6|721|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-608|6|616|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-609|6|828|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney| peritoneal mass (no sample provided),MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-610|6|763|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-611|6|830|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-612|6|816|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-613|6|620|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-614|6|459|Other deterministic changes|Whole body|n/a|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-615|6|411|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-616|6|411|Other deterministic changes|Whole body|EE|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-618|6|381|Other deterministic changes|Whole body|DEP|
1-6-6|n/a,n/a|1| 94|Rn-222 gas|1600|working level months|Inhalation| 1000 WL  low attached fraction, individual groups 1577,1586, 1594 WLM|116 (116 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 6 rats for short term study|1-6-6-619|6|381|Other deterministic changes|Whole body|DEP|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-505|7|300|Other deterministic changes|Whole body|EE|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-506|7|300|Other deterministic changes|Whole body|EE|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-543|7|701|Neoplasia benign|Lower respiratory system|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-544|7|628|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|Intestinal Adenocarcinoma Abdo Mass, Lobe A - 1mm?,MPATH: 549 - carcinoma|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-545|7|663|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-546|7|622|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma in Abdo D - 1mm|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-547|7|795|Neoplasia benign|Lower respiratory system|Leg mass (poorly sampled), patch lobe A|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-548|7|588|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-549|7|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic lymphoma ntestinal masses and enlarged spleen,MPATH: 513 - Lymphoid neoplasms|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-550|7|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L/fore leg Mass,MPATH: 513 - Lymphoid neoplasms|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-551|7|929|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm lung tumour lobe B 5mm|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-552|7|862|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 160 - metaplasia|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-553|7|897|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-554|7|871|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mmLung tumour lobe A 2mm, lung tumour lobe C 2mm, lung tumour lobe E five found one of which showed a degree of squamous change,MPATH: 268 - adenocarcinoma|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-555|7|796|Neoplasia benign|Lower respiratory system|Lung tumour lobe A 2mm, lung tumour lobe C 2mm, lung tumour lobe E five found one of which showed a degree of squamous change|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-556|7|488|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-557|7|681|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Lung tumour lobe E 2cm,MPATH: 268 - adenocarcinoma|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-558|7|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm  spread to the pleura Lung/diaphragm masses,MPATH: 561 - adenosquamous carcinoma|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-559|7|929|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mmLung tumour lobe B 4mm|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-560|7|296|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-561|7|605|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-562|7|559|Neoplasia benign|Lower respiratory system|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-563|7|551|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma Shoulder,MPATH: 408 - soft tissue fibrosarcoma|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-564|7|750|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-565|7|684|Neoplasia malignant|Lower respiratory system|Tumour <2mm Lung tumour lobe E 2mm|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-566|7|285|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic Leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-567|7|891|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-568|7|807|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-569|7|922|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-570|7|832|Other deterministic changes|Integumentary system|Keratin mass (benign) dorsal|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-571|7|716|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-572|7|472|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|non tumourous cyst abdome,MPATH: 62 - cyst|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-573|7|747|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-574|7|610|Other deterministic changes|Whole body|n/a|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-575|7|824|Neoplasia benign|Integumentary system,MA: 0000151 - skin|s/c Keratoacanthoma,MPATH: 218 - neoplasm|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-576|7|759|Neoplasia malignant|Other local manifestations and miscellaneus|Myxosarcoma Neck|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-577|7|340|Other deterministic changes|Whole body|EE|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-578|7|340|Other deterministic changes|Whole body|EE|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-579|7|285|Other deterministic changes|Whole body|DEPO|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-580|7|285|Other deterministic changes|Whole body|DEPO|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-622|7|412|Other deterministic changes|Whole body|DEP|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-623|7|412|Other deterministic changes|Whole body|DEP|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-626|7|386|Other deterministic changes|Whole body|EE|
1-6-7|n/a,n/a|1| 94|Rn-222 gas|3200|working level months|Inhalation| 1000 WL  low attached fraction, individual group 3095 WLM|44 (44 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 8 rats deposition and 2 rats for short term study|1-6-7-627|7|386|Other deterministic changes|Whole body|EE|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-842|8|831|Neoplasia benign|Lower respiratory system|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-843|8|807|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-844|8|675|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm lung metastasis Sq. cell carcinoma with sarcomatous element lung covered in masses,MPATH: 446 - squamous cell carcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-845|8|576|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-846|8|586|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma benign L foreleg|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-847|8|822|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Cystic kidneys,MPATH: 1 - cell and tissue damage|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-848|8|831|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-849|8|703|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-850|8|824|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-851|8|682|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|extrathoracic metastasis,MPATH: 549 - carcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-852|8|780|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-853|8|777|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-854|8|831|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-855|8|679|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Fibrous reactive tissue s/c mass L foreleg|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-856|8|831|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-857|8|804|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|+ lobar pneumonia Mass (no sample provided),MPATH: 212 - inflammation|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-858|8|672|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma mass R thorax,MPATH: 408 - soft tissue fibrosarcoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-859|8|369|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-860|8|831|Other deterministic changes|Lower respiratory system|+ foreign body reaction|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-861|8|619|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-862|8|827|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ Pleural effusion, mass lobe E,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-863|8|577|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Acute inflammation swollen leg|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-864|8|819|Neoplasia malignant|Lower respiratory system|Tumour <2mm lung metastasis ung tumour  lobe  A 2 mm metastesizing to E|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-865|8|496|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-866|8|710|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm Mass lobe E 5 mm,MPATH: 268 - adenocarcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-867|8|803|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-868|8|831|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm lung tumour lobe B 5mm|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-869|8|831|Neoplasia benign|Lower respiratory system|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-870|8|824|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 5<> 10mm,MPATH: 268 - adenocarcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-871|8|670|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma Mass L neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-872|8|795|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-873|8|790|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|Adenocarcinoma of stomach metastatising to mesenter Stomach mass, mesenteric nodulesy,MPATH: 549 - carcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-874|8|831|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-875|8|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Mass lobe E 1 cm,MPATH: 268 - adenocarcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-876|8|831|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-877|8|822|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-878|8|710|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-879|8|598|Other deterministic changes|Whole body|n/a|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-880|8|738|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-881|8|598|Neoplasia malignant|Other local manifestations and miscellaneus|Lung metastasis from unidentified primary|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-882|8|831|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-883|8|831|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-884|8|780|Hyperplastic changes|Lower respiratory system|+|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-885|8|819|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|Mammary adenocarcinoma,MPATH: 268 - adenocarcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-886|8|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm,MPATH: 268 - adenocarcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-887|8|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Mixed adenocarcinoma/ squamous cell carcinoma lung metastasis spread to the pleura Lungs covered in masses,MPATH: 561 - adenosquamous carcinoma|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-888|8|139|Other deterministic changes|Whole body|EE|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-889|8|139|Other deterministic changes|Whole body|EE|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-890|8|94|Other deterministic changes|Whole body|DEP|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-891|8|94|Other deterministic changes|Whole body|DEP|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-892|8|109|Other deterministic changes|Whole body|DEP|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-893|8|109|Other deterministic changes|Whole body|DEP|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-894|8|123|Other deterministic changes|Whole body|DEP|
1-6-8|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 250 WL  low attached fraction|54 (54 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-8-895|8|123|Other deterministic changes|Whole body|DEP|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-778|9|842|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 5<> 10mm lung metastasis Lung tumour Lobe B 8 mm with probable metastesis in E,MPATH: 268 - adenocarcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-779|9|740|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-780|9|827|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-781|9|818|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-782|9|801|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-783|9|656|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-784|9|857|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-785|9|741|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-786|9|835|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-787|9|647|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|Lung tumour lobe C 8mm,MPATH: 443 - inverted squamous papilloma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-788|9|857|Other deterministic changes|Whole body|No samples|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-789|9|857|Neoplasia malignant|Lower respiratory system|Tumour 5<> 10mm Lung tumour lobe C 8mm|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-790|9|729|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-791|9|742|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-792|9|724|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-793|9|549|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-794|9|689|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|+Alveolar sq. metaplasia with necrosis,MPATH: 171 - squamous metaplasia|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-795|9|244|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma, Mass under eye|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-796|9|660|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-797|9|632|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|Malignant renal adenocarcinoma, Swollen kidney  post mortem autolysis of unidentified lung lesion,MPATH: 549 - carcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-798|9|857|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-799|9|857|Neoplasia benign|Lower respiratory system|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-800|9|857|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-801|9|857|Neoplasia benign|Lower respiratory system|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-802|9|847|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland|Mass salivary gland lung tumours found = 6+ metasteses from sal. Gland,MPATH: 549 - carcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-803|9|843|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|R kidney cyst Adenocarcinoma,MPATH: 549 - carcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-804|9|605|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 160 - metaplasia|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-805|9|857|Neoplasia benign|Lower respiratory system|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-806|9|847|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-807|9|707|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma Throat mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-808|9|847|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma Mass L abdo,MPATH: 408 - soft tissue fibrosarcoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-809|9|727|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm ung tumour lobe E 1 cm,MPATH: 268 - adenocarcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-810|9|857|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 160 - metaplasia|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-811|9|812|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-812|9|857|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-813|9|640|Other deterministic changes|Whole body|Mass Blood/fat only|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-814|9|857|Other deterministic changes|Lower respiratory system|+ foreign body reaction|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-815|9|563|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-816|9|794|Other deterministic changes|Integumentary system|Hyperkeratosis dorsal mass|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-817|9|857|Hyperplastic changes|Lower respiratory system|+|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-818|9|790|Other deterministic changes|Integumentary system|Hyperkeratosis dorsal|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-819|9|149|Other deterministic changes|Whole body|n/a|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-820|9|718|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|Renal adenocarcinoma ? Metastatising to lung,MPATH: 549 - carcinoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-821|9|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-822|9|826|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcomaMass on rump,MPATH: 408 - soft tissue fibrosarcoma|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-823|9|787|Other deterministic changes|Whole body|EE|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-824|9|123|Other deterministic changes|Whole body|EE|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-825|9|123|Other deterministic changes|Whole body|EE|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-826|9|94|Other deterministic changes|Whole body|dep|
1-6-9|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 500 WL low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 6 rats deposition and 2 rats for short term study|1-6-9-827|9|94|Other deterministic changes|Whole body|dep|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-906|10|846|Neoplasia malignant|Lower respiratory system|Tumour > 10mm  lung tumour lobe C 1 cm|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-907|10|846|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-908|10|778|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-909|10|493|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-910|10|841|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-911|10|816|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-912|10|798|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-913|10|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-914|10|846|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-915|10|846|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-916|10|791|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-917|10|699|Neoplasia malignant|Lower respiratory system|Tumour > 10mm lung tumour lobe C 1cm, large urinary bladder NAF|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-918|10|846|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-919|10|846|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-920|10|801|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-921|10|745|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-922|10|833|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-923|10|721|Other deterministic changes|Integumentary system|Keratin only mass|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-924|10|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-925|10|813|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-926|10|760|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-927|10|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-928|10|823|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-929|10|168|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|?unidentified mass probably malignant,MPATH: 549 - carcinoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-930|10|750|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-931|10|688|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm  lobe E,MPATH: 446 - squamous cell carcinoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-932|10|838|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|Poor use rear legs,MPATH: 443 - inverted squamous papilloma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-933|10|756|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-934|10|727|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour <2mm,MPATH: 268 - adenocarcinoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-935|10|634|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-936|10|808|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-937|10|682|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-938|10|841|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-939|10|832|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-940|10|661|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour <2mm Bone deposit lobe c,MPATH: 446 - squamous cell carcinoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-941|10|535|Neoplasia benign|Other local manifestations and miscellaneus|s/c benign lipoma chest|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-942|10|474|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-943|10|339|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant rhabdomyosarcoma L foreleg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-944|10|846|Hyperplastic changes|Lower respiratory system|+|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-945|10|756|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm lung metastasis Thoracic content covered in masses multiple tumours,MPATH: 268 - adenocarcinoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-946|10|846|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-947|10|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-948|10|746|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-949|10|700|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-950|10|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-951|10|657|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma R forelimb,MPATH: 408 - soft tissue fibrosarcoma|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-952|10|109|Other deterministic changes|Whole body|EE|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-953|10|109|Other deterministic changes|Whole body|EE|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-954|10|89|Other deterministic changes|Whole body|n/a|
1-6-10|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 1000 WL  low attached fraction|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-10-955|10|89|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-712|11|654|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-713|11|626|Neoplasia benign|Other local manifestations and miscellaneus|Abdo. Mass|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-714|11|740|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-715|11|549|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Lung mass almost all of lobe E,MPATH: 446 - squamous cell carcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-716|11|420|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-717|11|650|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma L hind leg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-718|11|696|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-719|11|693|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-720|11|563|Other deterministic changes|Whole body|Advanced post mortem autolysis|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-721|11|765|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm lung tumour lobe E 1cm,MPATH: 268 - adenocarcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-722|11|879|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm lung metastasis|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-723|11|720|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 213 - acute inflammation|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-724|11|879|Hyperplastic changes|Lower respiratory system|+|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-725|11|834|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-726|11|808|Hyperplastic changes|Lower respiratory system|+|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-727|11|726|n/a|n/a|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-728|11|879|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm lung metastasis,MPATH: 268 - adenocarcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-729|11|752|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|Adenocarcinoma GI tract metastesising to lungs,MPATH: 549 - carcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-730|11|808|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-731|11|535|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-732|11|507|Neoplasia malignant|Bone among musculo-skeletal system diseases|Malignant osteosarcoma, multiple lung metastases Leg mass (L hind), nodules in lung|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-733|11|610|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-734|11|851|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-735|11|851|Other deterministic changes|Integumentary system|Non malignant hyperkeratosis|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-736|11|879|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm  Lung tumour lobe B 3mm,MPATH: 446 - squamous cell carcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-737|11|808|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Liver spotted, kidney cystic Multifocal necrosis, CPN,MPATH: 1 - cell and tissue damage|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-738|11|879|Hyperplastic changes|Lower respiratory system|+|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-739|11|787|Neoplasia malignant|Lower respiratory system|Tumour > 10mm Lung tumour lobe D 3 cm|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-740|11|516|Other deterministic changes|Reproductive system|Enlarged sem. Ves.Inflammation and necrosis|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-741|11|851|Neoplasia malignant|Lower respiratory system|Tumour > 10mmLung tumour lobe E 2cm|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-742|11|827|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-743|11|589|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-744|11|707|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-745|11|655|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney| cystic kidney large spleen NAF,MPATH: 1 - cell and tissue damage|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-746|11|668|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-747|11|573|Hyperplastic changes|Lower respiratory system|+|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-748|11|706|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-749|11|706|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma (malignant) L neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-750|11|879|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-751|11|879|Hyperplastic changes|Lower respiratory system|+|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-752|11|798|Neoplasia benign|Lower respiratory system|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-753|11|151|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma R side|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-754|11|879|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mm Lung tumour lobe C 1 mm,|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-755|11|720|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mmLung tumour lobe E 3 mm,MPATH: 268 - adenocarcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-756|11|787|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-757|11|696|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-758|11|867|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Lung tumour lobe B  1cm,MPATH: 561 - adenosquamous carcinoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-759|11|654|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-760|11|787|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-761|11|756|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Dorsal ulcer|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-762|11|587|Other deterministic changes|Whole body|n/a|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-763|11|597|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-764|11|131|Other deterministic changes|Whole body|EE|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-765|11|131|Other deterministic changes|Whole body|EE|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-766|11|112|Other deterministic changes|Whole body|Dep|
1-6-11|n/a,n/a|1| 94|Rn-222 gas|1000|working level months|Inhalation| 2000 WL  low attached fraction|56 (56 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study including 2 rats deposition and 2 rats for short term study|1-6-11-767|11|112|Other deterministic changes|Whole body|DEP|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1062|12|721|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1063|12|430|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1064|12|794|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1065|12|785|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1066|12|743|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1067|12|539|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant L foreleg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1068|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1069|12|811|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1070|12|640|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma Rside,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1071|12|763|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|GI adenocarcinoma malignant liver pale, spleen enlarged,MPATH: 549 - carcinoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1072|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1073|12|518|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1074|12|711|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1075|12|598|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant dorsal,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1076|12|752|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1077|12|392|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma L rear,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1078|12|806|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1079|12|811|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|Macrophage aggregation in alveoli with no reaction raised patches all lobes,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1080|12|807|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1081|12|706|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1082|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1083|12|704|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1084|12|767|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1085|12|721|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1086|12|759|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1087|12|710|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1088|12|715|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1089|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1090|12|612|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1091|12|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1092|12|658|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma L side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1093|12|703|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1094|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1095|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1096|12|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney pale, liver discoloured NAF,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1097|12|652|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1098|12|657|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1099|12|811|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1100|12|782|Changes due to an abnormal circulation|Cardiovascular system,MA: 0002447 - body cavity|,MPATH: 106 - fluid accumulation|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1101|12|664|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1102|12|728|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant 2 masses,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1103|12|524|Neoplasia benign|Integumentary system,MA: 0000151 - skin|s/c fibroadenoma benign R foreleg,MPATH: 407 - fibroma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1104|12|318|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|s/c malignant sarcoma R foreleg,MPATH: 551 - sarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1105|12|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1106|12|740|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1107|12|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic lymphoma malignant,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1108|12|493|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1109|12|640|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1110|12|173|Other deterministic changes|Whole body|EE|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1111|12|173|Other deterministic changes|Whole body|EE|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1417|12|551|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1418|12|483|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1419|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1420|12|670|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1421|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1422|12|811|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|Sarcoma undifferentiated,MPATH: 551 - sarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1423|12|664|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1424|12|708|Other deterministic changes|Lower respiratory system|+ patch of bronchopneumonia, lobe B, Liver pale NAF|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1425|12|858|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1426|12|657|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant R rear le,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1427|12|778|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1428|12|636|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1429|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1430|12|865|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1431|12|819|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1432|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1433|12|832|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1434|12|839|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys mottled,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1435|12|825|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1436|12|751|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1437|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1438|12|767|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma benign|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1439|12|807|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1440|12|857|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1441|12|737|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1442|12|611|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1443|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1444|12|858|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1445|12|774|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1446|12|855|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1447|12|714|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant, Dorsal mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1448|12|362|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1449|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1450|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1451|12|711|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1452|12|588|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1453|12|483|Other deterministic changes|Whole body|Mass on head not sampled|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1454|12|644|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1455|12|746|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1456|12|807|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1457|12|736|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1458|12|865|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1459|12|729|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1460|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1461|12|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia, Spleen enlarged, liver yellow,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1462|12|865|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1463|12|178|Other deterministic changes|Whole body|EE|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1464|12|178|Other deterministic changes|Whole body|EE|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1465|12|172|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 551 - sarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1466|12|749|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1667|12|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia Spleen large, liver mottled,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1668|12|630|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic lymphoma due to presence in thymus ?T cell lymphoblastic lymphoma,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1669|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1670|12|770|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1671|12|875|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1672|12|545|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1673|12|874|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1674|12|766|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1675|12|863|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1676|12|635|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Keratacanthoma benign Sore patch on side,MPATH: 218 - neoplasm|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1677|12|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1678|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1679|12|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1680|12|596|Other deterministic changes|Lower respiratory system|+Lobe B diffuse polymorph infiltration|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1681|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1682|12|612|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1683|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1684|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1685|12|831|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|adrenocortical adenocarcinoma with single metastesis to lobe B,MPATH: 549 - carcinoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1686|12|799|Other deterministic changes|Whole body|ADADC|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1687|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1688|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1689|12|791|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|Testis arteriitis|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1690|12|749|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1691|12|665|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1692|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1693|12|809|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1694|12|760|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1695|12|886|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ Dark spots on lungs,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1696|12|841|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1697|12|881|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1698|12|713|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1699|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1700|12|494|Other deterministic changes|Lower digestive tract|Squamous cell hyperplasia, Inlammation of pelvic tissues no malignancy|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1701|12|633|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1702|12|596|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1703|12|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1704|12|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|liver & lungs lymphoblastic leukeamia,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1705|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1706|12|858|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1707|12|885|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1708|12|660|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1709|12|705|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney| pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1710|12|671|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1711|12|886|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1712|12|819|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1713|12|842|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1714|12|789|Other deterministic changes|Whole body|squamoud cell carcinoma ? Not verifie|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1715|12|819|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1716|12|755|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1719|12|738|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+Pleural effusion,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1720|12|512|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1721|12|817|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, Mass no sample provided,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1722|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1723|12|789|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1724|12|724|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1725|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1726|12|815|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1727|12|749|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1728|12|619|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1729|12|737|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1730|12|706|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1731|12|748|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1732|12|749|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1733|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1734|12|735|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1735|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1736|12|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia infiltration with associated aseptic necrosis Orange peel liver,MPATH: 513 - Lymphoid neoplasms|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1737|12|783|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1738|12|769|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1739|12|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1740|12|661|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1741|12|595|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1742|12|735|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1743|12|817|Neoplasia malignant|Other local manifestations and miscellaneus| 1 metastesis from unknown primary|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1744|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1745|12|309|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1746|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1747|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1748|12|776|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1749|12|779|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1750|12|684|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1751|12|598|Other deterministic changes|Lower respiratory system|+ Foreign body reaction /Inhaled food/bedding|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1752|12|550|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1753|12|804|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1754|12|661|Hyperplastic changes|Lower respiratory system|+|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1755|12|800|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1756|12|484|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1757|12|531|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1758|12|596|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant, Leg mass, enlarged spleen,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1759|12|817|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1760|12|591|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1761|12|759|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1762|12|648|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1763|12|728|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1764|12|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign,MPATH: 266 - fibroadenoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1765|12|717|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1766|12|342|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1767|12|158|Other deterministic changes|Whole body|EE|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1768|12|158|Other deterministic changes|Whole body|EE|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1769|12|759|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1770|12|697|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1819|12|833|Other deterministic changes|Whole body|n/a|
1-6-12|n/a,n/a|1| 94|shamexposed|0|working level months|Inhalation| shamexposed|204 (204 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats for short term study|1-6-12-1820|12|707|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1262|13|833|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1263|13|770|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1264|13|844|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1265|13|692|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1366|13|865|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1717|13|886|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1718|13|719|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1821|13|852|Other deterministic changes|Hepato-pancreatic system|Multiple foci of necrosis liver|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1822|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1823|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1824|13|826|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1825|13|822|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1826|13|731|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1827|13|844|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1828|13|229|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma Mass chest/neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1829|13|792|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1830|13|514|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1831|13|783|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1832|13|447|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1833|13|713|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1834|13|363|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1835|13|602|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1836|13|678|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus|+,MPATH: 160 - metaplasia|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1837|13|591|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1838|13|364|Other deterministic changes|Lower digestive tract|Distended oesophagus|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1839|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1840|13|822|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1841|13|711|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1842|13|431|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant Abdo mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1843|13|829|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1844|13|761|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|adrenal adenocarcinoma,1 blood vessel of lung occluded by metastatic cells from adrenal,MPATH: 549 - carcinoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1845|13|767|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1846|13|641|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1847|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1848|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1849|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1850|13|478|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1851|13|741|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1852|13|698|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1853|13|852|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1854|13|816|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ ?related to cardiac failure,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1855|13|701|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1856|13|619|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys rough,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1857|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1858|13|770|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1859|13|783|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1860|13|678|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1861|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1862|13|581|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1863|13|852|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1864|13|743|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1865|13|645|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1866|13|521|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1867|13|852|Neoplasia malignant|Bloodvessels among cardiovascular system|Angiosarcoma malignant|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1868|13|285|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign,MPATH: 266 - fibroadenoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1869|13|790|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland|salivary adenocarcinoma,MPATH: 549 - carcinoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1870|13|750|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1871|13|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1872|13|651|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1873|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1874|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1875|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1876|13|729|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1877|13|773|Other deterministic changes|Whole body|enlarged pituitary|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1878|13|663|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1879|13|645|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1880|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1881|13|811|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1882|13|770|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1883|13|826|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+Pleural effusion,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1884|13|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, testes small,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1885|13|714|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1886|13|707|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1887|13|810|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1888|13|810|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1889|13|745|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1890|13|763|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1891|13|570|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1892|13|466|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1893|13|679|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1894|13|511|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|Sarcoma malignant cystic mass,MPATH: 551 - sarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1895|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1896|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1897|13|789|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+ Pleural effusion,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1898|13|619|Changes due to an abnormal circulation|Cardiovascular system,MA: 0002447 - body cavity|Blood filled cysts,MPATH: 106 - fluid accumulation|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1899|13|679|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1900|13|355|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1901|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1902|13|665|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1903|13|752|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1904|13|814|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|GI - polyarteritis nodosa pleural effusion|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1905|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1906|13|587|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|Mammary adenocarcinoma,MPATH: 268 - adenocarcinoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1907|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1908|13|557|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1909|13|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaema Liver enlarged,,MPATH: 513 - Lymphoid neoplasms|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1910|13|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic , pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1911|13|755|Other deterministic changes|Integumentary system|Squamous cyst- skin, mottled liver liver NAF|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1912|13|693|Neoplasia benign|Other local manifestations and miscellaneus|s/c lipoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1913|13|830|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1914|13|607|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign,MPATH: 266 - fibroadenoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1915|13|748|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1916|13|692|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1917|13|689|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1918|13|686|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Ornage peel kidney,MPATH: 1 - cell and tissue damage|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1919|13|633|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1920|13|693|Other deterministic changes|Whole body|n/a|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1971|13|888|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-1972|13|708|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
1-6-13|n/a,n/a|1| 94|none (controls)|0|working level months|Inhalation| cage controls|110 (110 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|n/a|1-6-13-2025|13|706|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1771|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1772|14|495|Other deterministic changes|Integumentary system|Benign dermal cyst|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1773|14|711|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1774|14|554|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1775|14|819|Neoplasia benign|Lower respiratory system|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1776|14|788|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1777|14|741|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1778|14|640|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1779|14|804|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|s/c mammary adenocarcinoma,MPATH: 268 - adenocarcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1780|14|700|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1781|14|803|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1782|14|724|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1783|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1784|14|761|Neoplasia malignant|Bloodvessels among cardiovascular system|Heamangiosarcoma,|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1785|14|755|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1786|14|667|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1787|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1788|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1789|14|833|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1790|14|644|Other deterministic changes|Whole body|Kidney cystic pleural effusion|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1791|14|833|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1792|14|825|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|Malignant adrenal cortical tumour,MPATH: 549 - carcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1793|14|735|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic liver pale liver NAF,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1794|14|564|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1795|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1796|14|833|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1797|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1798|14|494|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign Abdo mass,MPATH: 266 - fibroadenoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1799|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1800|14|710|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1801|14|589|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1802|14|556|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma benign|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1803|14|787|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1804|14|735|Neoplasia benign|Lower respiratory system|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1805|14|749|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic liver pale NAF,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1806|14|714|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1807|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1808|14|644|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1809|14|795|Other deterministic changes|Lower respiratory system|+ solitary lesion chronic pneumonitis|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1810|14|833|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1811|14|774|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1812|14|549|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia Spleen large, live mottled,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1813|14|768|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+severe pm autolysis,MPATH: 213 - acute inflammation|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1814|14|735|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1815|14|792|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1816|14|782|Neoplasia benign|Lower respiratory system|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1817|14|154|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1818|14|154|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1921|14|888|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1922|14|858|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1923|14|738|Changes due to an abnormal circulation|Cardiovascular system,MA: 0002447 - body cavity|Pleural effusio,MPATH: 106 - fluid accumulation|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1924|14|698|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|diaphragm nodule =liver,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1925|14|852|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1926|14|648|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1927|14|888|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1928|14|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukeamia,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1929|14|859|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|Small cell solid carcinoma of thyroid, lung metastasis from thyroid tracheal masss,MPATH: 278 - follicular adenocarcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1930|14|755|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1931|14|733|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1932|14|534|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1933|14|881|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1934|14|794|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1935|14|888|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|Sarcoma of intestine - malignant GIT/mesenteric nodules,MPATH: 551 - sarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1936|14|862|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|one tumour lobe E Pleural effusion,MPATH: 446 - squamous cell carcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1937|14|888|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1938|14|861|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1939|14|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1940|14|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1941|14|888|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1942|14|709|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1943|14|888|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1944|14|609|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1945|14|888|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1946|14|810|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1947|14|888|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|Enlarged pituitary,MPATH: 218 - neoplasm|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1948|14|683|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1949|14|810|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1950|14|361|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1951|14|885|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ Kidneys cystic, pleural effusion,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1952|14|672|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Pancreatic abscess|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1953|14|706|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1954|14|481|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Prostate enlarged, Mild inflammation prostate/bladder|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1955|14|888|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1956|14|781|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1957|14|895|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1958|14|881|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1959|14|881|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, liver pale lesions histol. Normal,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1960|14|481|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1961|14|734|Neoplasia benign|Lower respiratory system|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1962|14|566|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1963|14|852|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm  tumour lobe A 1cm,MPATH: 268 - adenocarcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1964|14|770|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1965|14|692|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1966|14|888|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1967|14|157|Other deterministic changes|Whole body|EE|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1968|14|157|Other deterministic changes|Whole body|EE|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1969|14|116|Other deterministic changes|Whole body|DEP|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1970|14|116|Other deterministic changes|Whole body|DEP|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1973|14|707|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1974|14|184|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|Nephroblastoma attached to kidney - malignant,MPATH: 218 - neoplasm|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1975|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1976|14|841|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1977|14|843|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1978|14|766|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|Pituitary enlarged,MPATH: 218 - neoplasm|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1979|14|846|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1980|14|805|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1981|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1982|14|800|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1983|14|733|Hyperplastic changes|Lower respiratory system|+ liver normal|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1984|14|592|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma (skin),MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1985|14|846|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1986|14|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1987|14|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic , Liver, lungs speckled,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1988|14|677|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1989|14|777|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1990|14|724|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1991|14|846|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1992|14|755|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1993|14|699|Other deterministic changes|Whole body|enlarged pituitary|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1994|14|628|Neoplasia malignant|Bloodvessels among cardiovascular system|Angiosarcoma malignant GIT masses|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1995|14|846|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1996|14|846|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1997|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1998|14|728|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-1999|14|846|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2000|14|631|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2001|14|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2002|14|711|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2003|14|662|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2004|14|504|Neoplasia benign|Other local manifestations and miscellaneus|s/c fibroma benign|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2005|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2006|14|467|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2007|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2008|14|564|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2009|14|706|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2010|14|464|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Mass L lobe lung,MPATH: 446 - squamous cell carcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2011|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2012|14|644|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys speckled,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2013|14|788|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2014|14|731|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2015|14|846|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2016|14|221|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2017|14|634|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2018|14|601|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2019|14|157|Other deterministic changes|Whole body|EE|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2020|14|157|Other deterministic changes|Whole body|EE|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2021|14|846|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2022|14|677|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2023|14|731|Degenerative changes|Lower respiratory system,MA: 0000415 - lung|+ pleural effusion,MPATH: 181 - fibrosis|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2024|14|682|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2026|14|766|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2027|14|653|Other deterministic changes|Whole body|advanced autolysis|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2028|14|781|Other deterministic changes|Whole body|mass on face no sample|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2029|14|640|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2030|14|811|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2031|14|641|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2032|14|787|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma, kidneys cystic,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2033|14|650|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2034|14|775|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2035|14|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2036|14|727|Neoplasia unclassified|Kidney among urinary system diseases,MA: 0000368 - kidney|Metastatic malignancy ? Of renal origin found in all lobes of lung kidney, liver bladder enlarged,MPATH: 218 - neoplasm|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2037|14|605|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2038|14|809|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2039|14|675|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2040|14|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|1 tumour lobe B, Pleural effusion,MPATH: 268 - adenocarcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2041|14|716|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2042|14|811|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2043|14|811|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2044|14|809|Other deterministic changes|Other local manifestations and miscellaneus|Scrotal mass, pleural effusion no cellular component|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2045|14|781|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2046|14|717|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Myxomatous fibrosarcoma malignant paragenital mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2047|14|611|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2048|14|811|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2049|14|787|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2050|14|811|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2051|14|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm,MPATH: 561 - adenosquamous carcinoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2052|14|804|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2053|14|699|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2054|14|793|Hyperplastic changes|Lower respiratory system|+ lobe C|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2055|14|769|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2056|14|811|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2057|14|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2058|14|804|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|++ Pleural effusion,MPATH: 213 - acute inflammation|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2059|14|789|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2060|14|811|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2061|14|811|Hyperplastic changes|Lower respiratory system|+ lobes B & E|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2062|14|811|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2063|14|571|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2064|14|699|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2065|14|699|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2066|14|795|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2067|14|720|Hyperplastic changes|Lower respiratory system|+ Pleural effusion|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2068|14|699|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2069|14|811|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2070|14|805|Hyperplastic changes|Lower respiratory system|+|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2071|14|722|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2072|14|738|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2073|14|642|Other deterministic changes|Whole body|n/a|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2074|14|123|Other deterministic changes|Whole body|DEP|
1-6-14|n/a,n/a|1| 94|Rn-222 gas|10|working level months|Inhalation| 15 WL low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 4 rats deposition and 6 rats for short term study|1-6-14-2075|14|123|Other deterministic changes|Whole body|DEP|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1212|15|654|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Oedema and inflammation Lfoot|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1213|15|736|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1214|15|378|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|L sides/c malignant fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1215|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1216|15|605|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Malignant fibrosarcoma, CPN,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1217|15|793|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1218|15|782|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1219|15|718|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1220|15|649|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1221|15|772|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1222|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1223|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1224|15|696|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1225|15|802|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1226|15|641|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Spleen large, lungs abnormal,MPATH: 549 - carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1227|15|728|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1228|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1229|15|798|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1230|15|654|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1231|15|766|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1232|15|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1233|15|637|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney adenocarcinoma,MPATH: 549 - carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1234|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1235|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1236|15|709|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1237|15|703|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1238|15|777|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1239|15|754|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1240|15|276|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Swollen L foot, Chronic inflammation|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1241|15|753|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1242|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1243|15|378|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma, Mass L rib cage,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1244|15|753|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1245|15|768|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1246|15|446|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1247|15|698|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic, pale lungs pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1248|15|608|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1249|15|731|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Cystic kidneys,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1250|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1251|15|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic lymphoma malignant,MPATH: 513 - Lymphoid neoplasms|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1252|15|703|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1253|15|809|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1254|15|686|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1255|15|575|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1256|15|809|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Mass lobe A,MPATH: 268 - adenocarcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1257|15|750|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|Mammary adenocarcinoma with sarcomatous change malignant, Mass on abdo,MPATH: 268 - adenocarcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1258|15|109|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1259|15|109|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1260|15|94|Other deterministic changes|Whole body|DEP|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1261|15|94|Other deterministic changes|Whole body|DEP|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1266|15|734|Neoplasia benign|Lower respiratory system|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1267|15|665|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1268|15|872|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 5<> 10mm lung metastasis, 6 mm masses lobes B and C (metastesis from B),MPATH: 446 - squamous cell carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1269|15|835|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1270|15|718|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1271|15|814|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1272|15|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|s/c mammary adenocarcinoma, *Abdo mass,MPATH: 268 - adenocarcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1273|15|662|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney rough,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1274|15|428|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1275|15|515|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1276|15|768|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1277|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1278|15|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1279|15|651|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma, Mass R side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1280|15|595|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant, Neck mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1281|15|818|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1282|15|437|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1283|15|795|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic, plueral effusion,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1284|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1285|15|854|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system| arteritis and calcification of testis, Liver enlarged, shrunken testis, bladder masses was infection|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1286|15|843|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma (Myxomatous) malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1287|15|633|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1288|15|857|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1289|15|383|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma,Mass R rib cage,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1290|15|476|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1291|15|872|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1292|15|742|Hyperplastic changes|Lower respiratory system|+|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1293|15|644|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1294|15|756|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1295|15|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia infiltrating liver and kidney, Large spleen, pale liver and kidneys,MPATH: 513 - Lymphoid neoplasms|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1296|15|786|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1297|15|641|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Ulcer|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1298|15|872|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys pale,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1299|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1300|15|774|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys rough,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1301|15|872|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1302|15|841|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1303|15|843|Neoplasia malignant|Lower respiratory system|Tumour 5<> 10mm,|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1304|15|758|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1305|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1306|15|872|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++Tumour lobe A 7mm,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1307|15|479|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1308|15|872|Hyperplastic changes|Lower respiratory system|+|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1309|15|658|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|1Dark lesions all lobe,Multiple foci of inflammation,MPATH: 213 - acute inflammation|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1310|15|557|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1311|15|744|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1312|15|820|Neoplasia benign|Lower respiratory system|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1313|15|828|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1314|15|131|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1315|15|131|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1316|15|735|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ Dark patches on lungs,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1317|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1318|15|697|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant, Abdo. Mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1319|15|832|Other deterministic changes|Whole body|MTM|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1320|15|808|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++ Pleural effusion,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1321|15|735|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1322|15|763|Neoplasia benign|Lower respiratory system|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1323|15|682|Neoplasia benign|Lower respiratory system|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1324|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1325|15|731|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1326|15|822|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1327|15|574|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1328|15|551|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma, Neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1329|15|793|Neoplasia systemic|Haematolymphatic system|?Myeloid leukaemia|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1330|15|588|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1331|15|689|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1332|15|728|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1333|15|821|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1334|15|684|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1335|15|661|Other deterministic changes|Whole body|Mass L eye no sample|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1336|15|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm lymph node invasion, Thymic/lung mass,MPATH: 446 - squamous cell carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1337|15|776|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1338|15|822|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1339|15|703|Neoplasia malignant|Other local manifestations and miscellaneus|s/c myxosarcoma malignan, Leg mass|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1340|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1341|15|746|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1342|15|818|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1343|15|664|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1344|15|822|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1345|15|804|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1346|15|831|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1347|15|392|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1348|15|795|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1349|15|756|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic, pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1350|15|677|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1351|15|822|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 2<> 5mm,  lung tumour lobe A 5mm,MPATH: 268 - adenocarcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1352|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1353|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1354|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1355|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1356|15|473|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1357|15|832|Hyperplastic changes|Lower respiratory system|+|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1358|15|832|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1359|15|761|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1360|15|832|Hyperplastic changes|Lower respiratory system|+ Mass lobe E|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1361|15|822|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1362|15|130|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1363|15|130|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1364|15|112|Other deterministic changes|Whole body|DEP|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1365|15|112|Other deterministic changes|Whole body|DEP|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1367|15|788|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1368|15|843|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1369|15|769|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1370|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1371|15|871|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney blotchy testicular arteritis,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1372|15|871|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Keratoacanthoma benign,MPATH: 218 - neoplasm|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1373|15|731|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1374|15|826|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1375|15|743|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1376|15|755|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1377|15|735|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1378|15|685|Neoplasia benign|Lower respiratory system|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1379|15|872|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma, lipoma masses 2x|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1380|15|735|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1381|15|592|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1382|15|872|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1383|15|738|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1384|15|670|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1385|15|843|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1386|15|626|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1387|15|492|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1388|15|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1389|15|861|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1390|15|865|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1391|15|227|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1392|15|518|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1393|15|853|Neoplasia malignant|Bloodvessels among cardiovascular system|Heamangiosarcoma malignant, GI mass|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1394|15|863|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1395|15|733|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1396|15|536|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1397|15|690|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1398|15|632|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1399|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1400|15|776|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1401|15|760|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys rough, liver rough, liver NAF,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1402|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1403|15|872|Neoplasia malignant|Bloodvessels among cardiovascular system| mesenteric heamangiosarcoma large mes. LN|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1404|15|872|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1405|15|814|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1406|15|853|Neoplasia benign|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|Adrenal cortical adenoma,MPATH: 270 - adenoma|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1407|15|872|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1408|15|769|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1409|15|766|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1410|15|842|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1411|15|835|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1412|15|522|Other deterministic changes|Whole body|n/a|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1413|15|131|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1414|15|131|Other deterministic changes|Whole body|EE|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1415|15|115|Other deterministic changes|Whole body|DEP|
1-6-15|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 6 rats deposition and 8 rats for short term study|1-6-15-1416|15|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1467|16|796|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1468|16|858|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1469|16|842|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1470|16|598|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1471|16|720|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1472|16|767|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1473|16|836|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1474|16|860|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1475|16|804|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1476|16|860|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1477|16|860|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1478|16|860|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1479|16|860|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1480|16|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign left,MPATH: 266 - fibroadenoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1481|16|782|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1482|16|674|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1483|16|758|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1484|16|460|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1485|16|678|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1486|16|853|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1487|16|503|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Cystic kidneys, pleural effusion,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1488|16|609|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1489|16|847|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1490|16|674|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1491|16|726|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1492|16|843|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1493|16|437|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign,MPATH: 266 - fibroadenoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1494|16|846|Neoplasia malignant|Bloodvessels among cardiovascular system|LN heamangiosarcoma, testis arteritis|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1495|16|860|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1496|16|729|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1497|16|761|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, Mass, gut nodules,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1498|16|860|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1499|16|850|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys discoloured,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1500|16|678|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1501|16|714|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant Peritoneal mass,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1502|16|860|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1503|16|779|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1504|16|542|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1505|16|852|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys mottled,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1506|16|685|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1507|16|445|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1508|16|657|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1509|16|706|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1510|16|632|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1511|16|858|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1512|16|684|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1513|16|130|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1514|16|130|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1515|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1516|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1517|16|446|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Ulcer on neck not sampled|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1518|16|764|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1519|16|609|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1520|16|812|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1521|16|467|Neoplasia malignant|Other local manifestations and miscellaneus|s/c malignant myxosarcoma Rforeleg|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1522|16|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour 5<> 10mm, lobe C Mixed squamous cell and adenocarcinoma malignant lobe C,MPATH: 561 - adenosquamous carcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1523|16|737|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1524|16|582|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1525|16|800|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1526|16|812|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1527|16|485|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|Malignant adenocarcinoma of kidney metastesising to lung,MPATH: 549 - carcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1528|16|797|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1529|16|812|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1530|16|797|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1531|16|812|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1532|16|465|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1533|16|812|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1534|16|769|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1535|16|812|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, nodular mesentery mesenteric arteritis,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1536|16|514|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1537|16|812|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1538|16|739|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Mass,kidney granula, Keratin in cystic mass,,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1539|16|801|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1540|16|704|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1541|16|657|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1542|16|648|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1543|16|579|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1544|16|812|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1545|16|616|Other deterministic changes|Whole body|Thin, sore eyes, long teeth|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1546|16|801|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1547|16|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|Mammary fibroadenoma benign L side,MPATH: 266 - fibroadenoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1548|16|697|Neoplasia malignant|Other local manifestations and miscellaneus|Myxosarcoma malignant Peritoneal mass|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1549|16|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Mass lobe D 1cm,MPATH: 446 - squamous cell carcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1550|16|623|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma R side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1551|16|673|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1552|16|553|Neoplasia malignant|Other local manifestations and miscellaneus|Metastases from malignant sarcoma. Primary not identified|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1553|16|812|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1554|16|633|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1555|16|812|Neoplasia benign|Lower respiratory system|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1556|16|724|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1557|16|812|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1558|16|370|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma metastesising to lungs R leg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1559|16|759|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1560|16|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumour > 10mm Poorly differentiated BrAc lobe A,MPATH: 268 - adenocarcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1561|16|687|Neoplasia benign|Lower respiratory system|Poorly differentiated BrAc|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1562|16|812|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1563|16|129|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1564|16|129|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1565|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1566|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1567|16|728|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1568|16|666|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1569|16|752|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1570|16|549|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1571|16|639|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1572|16|790|Neoplasia malignant|Other local manifestations and miscellaneus|Liposarcoma malignant|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1573|16|818|Neoplasia malignant|Bloodvessels among cardiovascular system|heamangiosarcoma kidney|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1574|16|693|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1575|16|837|Neoplasia benign|Lower respiratory system|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1576|16|654|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1577|16|801|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1578|16|681|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1579|16|837|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1580|16|777|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1581|16|612|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1582|16|753|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1583|16|783|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1584|16|717|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+ Pleural effusion,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1585|16|837|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1586|16|651|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1587|16|340|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1588|16|689|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1589|16|805|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|Enlarged pituitary,MPATH: 218 - neoplasm|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1590|16|823|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|Adenocarcinoma Kidneys pale, liver spotted,MPATH: 549 - carcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1591|16|494|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1592|16|837|Neoplasia benign|Lower respiratory system|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1593|16|669|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1594|16|754|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma benign|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1595|16|806|Neoplasia benign|Lower respiratory system|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1596|16|787|Hyperplastic changes|Lower respiratory system|++|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1597|16|655|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1598|16|627|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1599|16|654|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1600|16|773|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1601|16|823|Neoplasia benign|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| benign adrenal adenoma,MPATH: 270 - adenoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1602|16|750|Neoplasia benign|Lower respiratory system|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1603|16|715|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1604|16|837|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1605|16|824|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Trichoepithelioma of skin,,MPATH: 218 - neoplasm|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1606|16|837|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1607|16|837|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1608|16|837|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1609|16|837|Neoplasia benign|Lower respiratory system|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1610|16|837|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1611|16|340|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|s/c malignant mixed cell sarcoma,MPATH: 551 - sarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1612|16|837|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1613|16|129|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1614|16|129|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1615|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1616|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1617|16|827|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Calcified mammary gland secretion, abcesses in lymph nodeNeck nodule, neck lymph node|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1618|16|820|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1619|16|832|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1620|16|696|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1621|16|647|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1622|16|842|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1623|16|776|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1624|16|691|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1625|16|424|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma neck,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1626|16|669|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1627|16|815|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1628|16|843|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1629|16|790|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1630|16|497|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma dorsal,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1631|16|843|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Malignant fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1632|16|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|lymphoblastic leukaemia Mes, pancreas, kidney pale, thymus,MPATH: 513 - Lymphoid neoplasms|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1633|16|604|Other deterministic changes|Other local manifestations and miscellaneus|Lump on spleen not sampled|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1634|16|627|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|s/c undifferentiated sarcoma malignant abdo,MPATH: 551 - sarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1635|16|830|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|CPN with abcess mass,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1636|16|817|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1637|16|609|Neoplasia benign|Other local manifestations and miscellaneus|s/c/lipoma benign R abdo|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1638|16|551|Hyperplastic changes|Lower respiratory system|+|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1639|16|599|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1640|16|836|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1641|16|840|Neoplasia malignant|Bloodvessels among cardiovascular system|Heamangiosarcoma malignant mesenteric mass|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1642|16|683|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1643|16|657|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1644|16|809|Other deterministic changes|Whole body|some  pleural fluid|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1645|16|801|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000142 - thymus|Squamous cell carcinoma thymic mass,MPATH: 549 - carcinoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1646|16|749|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1647|16|759|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1648|16|633|Other deterministic changes|Whole body|mass on skull|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1649|16|665|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1650|16|653|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1651|16|815|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1652|16|724|Neoplasia benign|Integumentary system,MA: 0000151 - skin|?keratoacanthomas benign 2x pm autolysis,MPATH: 218 - neoplasm|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1653|16|843|Neoplasia benign|Other local manifestations and miscellaneus|lipoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1654|16|782|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1655|16|843|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney discoloured,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1656|16|798|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1657|16|843|Neoplasia benign|Other local manifestations and miscellaneus|Both lipoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1658|16|721|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma - malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1659|16|767|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1660|16|623|Other deterministic changes|Integumentary system|Keratitis dorsal mass|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1661|16|843|Other deterministic changes|Whole body|n/a|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1662|16|308|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|Malignant fibroadenoma probably mammary with metastesis in lung,MPATH: 218 - neoplasm|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1663|16|129|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1664|16|129|Other deterministic changes|Whole body|EE|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1665|16|115|Other deterministic changes|Whole body|DEP|
1-6-16|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 150 WL*  high attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 8 rats for short term study|1-6-16-1666|16|115|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-962|17|724|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-963|17|777|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-964|17|669|Changes due to an abnormal circulation|Cardiovascular system,MA: 0002447 - body cavity|Bladder/GI mass Heamorrhagic cyst,MPATH: 106 - fluid accumulation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-965|17|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-966|17|824|Hyperplastic changes|Lower respiratory system|++|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-967|17|768|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-968|17|340|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-969|17|824|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-970|17|696|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-971|17|717|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-972|17|396|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney speckled, GIT blockage,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-973|17|630|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-974|17|717|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-975|17|769|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-976|17|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Lymphoblastic leukaemia,MPATH: 513 - Lymphoid neoplasms|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-977|17|824|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-978|17|800|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|? In remarks to size etc pm autolysis of 4mm mass in lobe E lung tumor not identified,MPATH: 446 - squamous cell carcinoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-979|17|556|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-980|17|745|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-981|17|782|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-982|17|781|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-983|17|458|Other deterministic changes|Other local manifestations and miscellaneus|Mass R eye No sample|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-984|17|792|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-985|17|566|Other deterministic changes|Integumentary system|Dermal fibroblast proliferation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-986|17|700|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-987|17|517|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-988|17|824|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-989|17|824|Neoplasia benign|Lower respiratory system|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-990|17|789|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|++,MPATH: 213 - acute inflammation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-991|17|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Malignant histio cytic lymphoma throat,MPATH: 513 - Lymphoid neoplasms|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-992|17|689|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-993|17|816|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|malignant bladder carcinoma urinary masses,MPATH: 549 - carcinoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-994|17|824|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-995|17|824|Neoplasia malignant|Lower respiratory system|Tumour 2<> 5mmTumour lobe C 4mm|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-996|17|672|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-997|17|824|Hyperplastic changes|Lower respiratory system|++|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-998|17|824|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-999|17|654|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Malignant fibrosarcoma, GI mass, liver pale, spleen enlarged liver NAF,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1000|17|563|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000420 - lung alveolus|+Facial mass not sampled,MPATH: 213 - acute inflammation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1001|17|824|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1002|17|824|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma benign|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1003|17|717|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1004|17|661|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1005|17|778|Other deterministic changes|Other local manifestations and miscellaneus|mass kidney no sample provided|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1006|17|487|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1007|17|733|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1008|17|102|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1009|17|102|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1010|17|88|Other deterministic changes|Whole body|Dep|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1011|17|88|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1012|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1013|17|541|Hyperplastic changes|Lower respiratory system|*|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1014|17|665|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1015|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1016|17|779|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1017|17|605|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1018|17|809|Other deterministic changes|Lower respiratory system|1 alveolar oedema, 1 minimal type II proliferation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1019|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1020|17|774|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1021|17|809|Neoplasia malignant|Lower respiratory system|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1022|17|612|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant R side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1023|17|782|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1024|17|797|Neoplasia benign|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|thyroid noduleSquamous cell papilloma benign,,MPATH: 270 - adenoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1025|17|712|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1026|17|781|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1027|17|734|Other deterministic changes|Whole body|kidney cystic|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1028|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1029|17|744|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1030|17|694|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1031|17|770|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1032|17|766|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1033|17|740|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1034|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1035|17|346|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant Lear,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1036|17|729|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1037|17|654|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1038|17|559|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1039|17|577|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1040|17|809|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1041|17|551|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1042|17|684|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1043|17|700|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1044|17|721|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma throat,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1045|17|685|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1046|17|623|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1047|17|732|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1048|17|728|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1049|17|712|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1050|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1051|17|504|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c malignant fibrosarcoma L foreleg,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1052|17|752|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1053|17|717|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1054|17|510|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1055|17|809|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1056|17|672|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, mesenteric nodules (cysts),MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1057|17|102|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1058|17|102|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1059|17|102|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1060|17|89|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1061|17|89|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1112|17|802|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney small cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1113|17|788|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1114|17|605|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1115|17|714|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1116|17|535|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Bladder sem.ves. Inflammation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1117|17|693|Changes due to an abnormal circulation|Cardiovascular system,MA: 0002447 - body cavity|,MPATH: 106 - fluid accumulation|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1118|17|779|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1119|17|687|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1120|17|769|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1121|17|693|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1122|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1123|17|738|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|s/c abcess abdomen|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1124|17|738|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1125|17|820|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1126|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1127|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1128|17|220|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1129|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1130|17|817|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1131|17|686|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1132|17|643|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidneys cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1133|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1134|17|726|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1135|17|808|Neoplasia benign|Other local manifestations and miscellaneus|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1136|17|746|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1137|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1138|17|600|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1139|17|514|Metabolic abnormalities|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|Diffuse fat infiltration of liver liver yellow ?inner ear disease,MPATH: 591 - fatty infiltration|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1140|17|823|Neoplasia benign|Lower respiratory system|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1141|17|611|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1142|17|699|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1143|17|619|Other deterministic changes|Whole body|Gut empty apart from gas|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1144|17|717|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1145|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1146|17|632|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1147|17|823|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1148|17|733|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1149|17|823|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1150|17|745|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1151|17|787|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Kidney cystic, liver pale lesions artefact,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1152|17|651|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant R side,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1153|17|753|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1154|17|739|Neoplasia malignant|Bloodvessels among cardiovascular system|Malignant heamangiosarcoma peritoneal/abdominal wall|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1155|17|801|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1156|17|661|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1157|17|102|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1158|17|102|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1159|17|102|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1160|17|88|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1161|17|88|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1162|17|625|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1163|17|844|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1164|17|832|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1165|17|521|Other deterministic changes|Other local manifestations and miscellaneus|mass abcess no sample|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1166|17|761|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1167|17|527|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1168|17|527|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1169|17|776|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1170|17|844|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1171|17|488|Other deterministic changes|Other local manifestations and miscellaneus|Non malignant cyst mucoid mass|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1172|17|612|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1173|17|844|Neoplasia benign|Integumentary system,MA: 0000151 - skin|Keratoacanthoma,MPATH: 218 - neoplasm|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1174|17|625|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1175|17|769|Neoplasia benign|Lower respiratory system|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1176|17|572|Other deterministic changes|Other local manifestations and miscellaneus|Liver yellow, spleen large, Abdo. Fat fibrousMass|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1177|17|571|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1178|17|458|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1179|17|775|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1180|17|742|Neoplasia benign|Other local manifestations and miscellaneus|Lipoma benign|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1181|17|844|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1182|17|768|Hyperplastic changes|Lower respiratory system|+|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1183|17|844|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1184|17|844|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1185|17|626|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1186|17|713|Hyperplastic changes|Lower respiratory system,MA: 0001480 - respiratory tract epithelium|+,MPATH: 134 - hyperplasia|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1187|17|719|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1188|17|808|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|Fibrosarcoma malignant,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1189|17|703|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1190|17|490|Other deterministic changes|Other local manifestations and miscellaneus|Non malignant unidentified tissue* Mass R ribs|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1191|17|773|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1192|17|844|Neoplasia malignant|Lower respiratory system|Tumour > 10mm Tumour lobe C 1cm|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1193|17|844|Neoplasia benign|Lower respiratory system|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1194|17|648|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1195|17|844|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1196|17|844|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1197|17|644|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|s/c fibrosarcoma malignant tail,MPATH: 408 - soft tissue fibrosarcoma|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1198|17|741|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1199|17|777|Neoplasia benign|Other local manifestations and miscellaneus|Fibroma benign|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1200|17|831|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1201|17|586|Other deterministic changes|Lower respiratory system|=+ benign round cell reaction GIT black|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1202|17|677|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1203|17|790|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1204|17|762|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|Ascites, Kidney cystic,MPATH: 1 - cell and tissue damage|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1205|17|617|Other deterministic changes|Whole body|n/a|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1206|17|735|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|+,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1207|17|776|Hyperplastic changes|Lower respiratory system,MA: 0000420 - lung alveolus,MA: 0000420 - lung alveolus|++,MPATH: 585 - acidophilic macrophage pneumonia,MPATH: 303 - pseudomyxoma peritonei|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1208|17|103|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1209|17|103|Other deterministic changes|Whole body|EE|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1210|17|87|Other deterministic changes|Whole body|DEP|
1-6-17|n/a,n/a|1| 94|Rn-222 gas|100|working level months|Inhalation| 1000 WL  low attached fraction|200 (200 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Male|Young Adult|lifespan study additional 8 rats deposition and 10 rats for short term study|1-6-17-1211|17|87|Other deterministic changes|Whole body|DEP|
		
